# Medirom Healthcare Technologies Inc.: Form 20-F for the period ended Dec 31, 2023

- Company: [Medirom Healthcare Technologies Inc.](/companies/mrm.md) (CIK 1819704)
- Form: 20-F
- Filed: 2024-06-18
- Accepted by EDGAR: Jun 18, 2024, 21:29 ET
- Period: 2023-12-31
- Accession: 0001558370-24-009293
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1819704/000155837024009293/mrm-20231231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1819704/000155837024009293/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2023-01-01 to 2023-12-31 | JPY 6.83bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Selling, general and administrative | 12 months, 2023-01-01 to 2023-12-31 | JPY 1.96bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2023-01-01 to 2023-12-31 | −JPY 391.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2023-01-01 to 2023-12-31 | JPY 36.9m | us-gaap:InterestExpense |
| Income tax | 12 months, 2023-01-01 to 2023-12-31 | −JPY 94.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2023-01-01 to 2023-12-31 | JPY 115.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2023-01-01 to 2023-12-31 | JPY 22.34 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2023-01-01 to 2023-12-31 | JPY 23.64 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2023-01-01 to 2023-12-31 | 5,166,653 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2023-01-01 to 2023-12-31 | −JPY 631.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2023-01-01 to 2023-12-31 | JPY 135.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2023-12-31 | $755.0k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2023-12-31 | JPY 1.76bn | us-gaap:AssetsCurrent |
| Total assets | at 2023-12-31 | JPY 6.85bn | us-gaap:Assets |
| Current liabilities | at 2023-12-31 | JPY 3.56bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2023-12-31 | JPY 6.63bn | us-gaap:Liabilities |
| Long-term debt | at 2023-12-31 | JPY 1.05bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2023-12-31 | JPY 100.4m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2023-12-31 | JPY 400.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2023-12-31 | JPY 210.9m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2023-12-31 | 4,882,500 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1819704/000155837024009293/mrm-20231231x20f.htm

Filed Jun 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-009293. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.